Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2026-01-07 @ 1:10 AM
Study NCT ID:
NCT04157933
Status:
COMPLETED
Last Update Posted:
2020-11-04
First Post:
2019-11-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease
Sponsor:
Alexza Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-16
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-06
Completion Date Type:
ACTUAL
First Submit Date:
2019-11-01
First Submit QC Date:
None
Study First Post Date:
2019-11-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-03
Last Update Post Date:
2020-11-04
Last Update Post Date Type:
ACTUAL